Abstract:The huge part of population in developed countries is overweight or obese. Obesity is often determined by body mass index (BMI) but new accurate methods and ratios have recently appeared to measure body fat or fat located in the intestines. Early diagnosis of obesity is crucial since it is considered an increasing colorectal cancer risk factor. On the one hand, colorectal cancer has been strongly associated with lifestyle factors. A diet rich in red and processed meats may increase colorectal cancer risk; however, high-fiber diets (grains, cereals and fruits) have been associated with a decreased risk of colorectal cancer. Other life-style factors associated with obesity that also increase colorectal cancer risk are physical inactivity, smoking and high alcohol intake. Cutting-edge studies reported that high-risk transformation ability of adipose tissue is due to production of different pro-inflammatory cytokines like IL-8, IL-6 or IL-2 and other enzymes like lactate dehydrogenase (LDH) and tumour necrosis factor alpha (TNFα). Furthermore, oxidative stress produces fatty-acid peroxidation whose metabolites possess very high toxicities and mutagenic properties. 4-hydroxy-2-nonenal (4-HNE) is an active compounds that upregulates prostaglandin E2 which is directly associated with high proliferative colorectal cancer. Moreover, 4-HNE deregulates cell proliferation, cell survival, differentiation, autophagy, senescence, apoptosis and necrosis via mitogen-activated protein kinase (MAPK), phosphoinositide 3-kinase (PIK3CA)-AKT and protein kinase C pathways. Other product of lipid peroxidation is malondialdehyde (MDA) being able to regulate insulin through WNT-pathway as well as having demonstrated its mutagenic capability. Accumulation of point mutation enables genomic evolution of colorectal cancer described in the model of Fearon and Vogelstein. In this review, we will summarize different determination methods and techniques to assess a truthfully diagnosis and we will explain some of the capabilities that performs adipocytes as the largest endocrine organ.

Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation

Lipids and adipocytes involvement in tumor progression with a focus on obesity and diet

Adipose Tissue, Obesity and Adiponectin: Role in Endocrine Cancer Risk

Obesity-induced changes in cancer cells and their microenvironment: Mechanisms and therapeutic perspectives to manage dysregulated lipid metabolism

Adipokines and epithelial-mesenchymal transition (EMT) in cancer

The Role of Adipokines in Tumor Progression and Its Association with Obesity

Obesity and colorectal cancer: molecular features of adipose tissue

Obesity, Dietary Fats, and Gastrointestinal Cancer Risk-Potential Mechanisms Relating to Lipid Metabolism and Inflammation

Adipocyte Microenvironment in Ovarian Cancer: A Critical Contributor?

Interaction between adipose tissue and cancer cells: role for cancer progression

The impact of obesity and adipokines on breast and gynecologic malignancies

Obesity‐Associated Myeloid Immunosuppressive Cells, Key Players in Cancer Risk and Response to Immunotherapy

Obesity and adipose tissue impact on T-cell response and cancer immune checkpoint blockade therapy

Changed adipocytokine concentrations in colorectal tumor patients and morbidly obese patients compared to healthy controls

Obesity and prostate cancer — microenvironmental roles of adipose tissue

Cancer-associated adipocytes: key players in breast cancer progression

Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression

Unravelling the role of obesity and lipids during tumor progression

Obesity and cancer risk: Emerging biological mechanisms and perspectives

Adipose tissue and adipocytes support tumorigenesis and metastasis

Obesity and Breast Cancer: The Role of Crown-Like Structures in Breast Adipose Tissue in Tumor Progression, Prognosis, and Therapy